Related Experiment Video
Updated: May 25, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
HIV-related bronchiectasis in children: an emerging spectre in high tuberculosis burden areas
R Masekela1, R Anderson, T Moodley
1Department of Paediatrics and Child Health, Division of Paediatric Pulmonology, Steve Biko Academic Hospital, University of Pretoria, Pretoria, South Africa. refiloe.masekela@up.ac.za
Insights
Children with HIV-related bronchiectasis face significant risks and morbidity, often diagnosed after age six. Their immune systems remain active despite immunosuppression, indicating complex disease mechanisms.
Area of Science:
- Pediatric Infectious Diseases
- Pulmonology
- Immunology
Background:
- Children with Human Immunodeficiency Virus (HIV) have an eleven-fold increased risk of acute lower respiratory tract infections.
- This heightened risk can lead to airway destruction and bronchiectasis in HIV-infected children.
Purpose of the Study:
- To investigate predisposing factors for bronchiectasis development in children within a developing country context.
- To understand the clinical characteristics and immunological profile of pediatric HIV-associated bronchiectasis.
Main Methods:
- Enrolled children aged 6-14 years with HIV-related bronchiectasis.
- Collected data on demographics, sputum for pathogens (bacteriology, virology, tuberculosis), cytokines, and performed spirometry.
- Assessed HIV staging, immunoglobulins, specific IgE levels for allergens, and serum cytokines.
Main Results:
- Haemophilus influenzae and parainfluenzae were the predominant organisms in sputum.
- Median forced expiratory volume in 1 second was 53%, indicating significant airflow limitation.
- Interleukin-8 was the predominant cytokine; elevated IgE levels were not clearly linked to atopy, and environmental tobacco smoke exposure showed no correlation with CD4 count.
Conclusions:
- Pediatric HIV-related bronchiectasis is typically diagnosed after age six and is associated with substantial morbidity.
- Despite HIV-induced immunosuppression, immune stimulation mechanisms appear to remain functional in these children.
Background:
Human immunodeficiency virus (HIV) infected children have an eleven-fold risk of acute lower respiratory tract infection. This places HIV-infected children at risk of airway destruction and bronchiectasis.
Objective:
To study predisposing factors for the development of bronchiectasis in a developing world setting.
Methods:
Children with HIV-related bronchiectasis aged 6-14 years were enrolled. Data were collected on demographics, induced sputum for tuberculosis, respiratory viruses (respiratory syncytial virus), influenza A and B, parainfluenza 1-3, adenovirus and cytomegalovirus), bacteriology and cytokines. Spirometry was performed. Blood samples were obtained for HIV staging, immunoglobulins, immunoCAP®-specific immunoglobulin E (IgE) for common foods and aeroallergens and cytokines.
Results:
In all, 35 patients were enrolled in the study. Of 161 sputum samples, the predominant organisms cultured were Haemophilus influenzae and parainfluenzae (49%). The median forced expiratory volume in 1 second of all patients was 53%. Interleukin-8 was the predominant cytokine in sputum and serum. The median IgE level was 770 kU/l; however, this did not seem to be related to atopy; 36% were exposed to environmental tobacco smoke, with no correlation between exposure and CD4 count.
Conclusion:
Children with HIV-related bronchiectasis are diagnosed after the age of 6 years and suffer significant morbidity. Immune stimulation mechanisms in these children are intact despite the level of immunosuppression.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
